Reckitt Benckiser Group (LON:RB) PT Set at GBX 9,300 by Barclays

Reckitt Benckiser Group (LON:RBGet Rating) received a GBX 9,300 ($116.18) price target from investment analysts at Barclays in a research note issued on Tuesday, Borsen Zeitung reports.

Several other equities research analysts have also recently commented on RB. JPMorgan Chase & Co. set a GBX 8,500 ($106.18) price target on Reckitt Benckiser Group in a research note on Wednesday, April 27th. Credit Suisse Group set a GBX 7,700 ($96.19) price objective on Reckitt Benckiser Group in a report on Wednesday, March 30th. UBS Group set a GBX 7,700 ($96.19) price objective on Reckitt Benckiser Group in a report on Wednesday, April 27th. Sanford C. Bernstein set a GBX 5,300 ($66.21) price objective on Reckitt Benckiser Group in a report on Friday. Finally, Jefferies Financial Group set a GBX 5,000 ($62.46) price objective on Reckitt Benckiser Group in a report on Friday. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Reckitt Benckiser Group currently has an average rating of “Buy” and a consensus target price of GBX 7,050.91 ($88.08).

Reckitt Benckiser Group has a 52 week low of GBX 5,782 ($72.23) and a 52 week high of GBX 8,020 ($100.19). The company has a current ratio of 0.77, a quick ratio of 0.53 and a debt-to-equity ratio of 116.01. The company has a market capitalization of £48.36 billion and a P/E ratio of 40.79.

About Reckitt Benckiser Group (Get Rating)

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.